IP tension between universities and Mann Foundation
The Mann Foundation seeks to promote commercialization of biomedical technologies. The Mann Foundation CEO is Stephen Dahms, a former chemistry professor at San Diego.
IPBiz thinks there's a message here for the IP group at CIRM, and for the proponents of Proposition 71 in California, and the advocates of stem cell research in New Jersey.
0 Comments:
Post a Comment
<< Home